Femoral Nerve Block Compared to Exparel in Total Knee Replacement

Launched by THE NEW ENGLAND BAPTIST HOSPITAL · Jun 15, 2015

Keywords

ClinConnect Summary

A prospective, single blind study comparing femoral nerve blockade and intraarticular posterior capsular injection to interarticular injection of bupivicaine and liposomal bupivicaine (Exparel) alone.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • • Patients between the ages of 18 - 73 who are undergoing primary, unilateral, Total Knee Replacement at the New England Baptist Hospital in Boston, Massachusetts are eligible to participate.
• Exclusion Criteria:
• • Patients with Revision or Complex Total Knee Replacements and are under the age of 18, or over the age of 73 will be excluded.
• • Patients with an ASA 4 level will be excluded.
• • Patients with a Body Mass Index of less than 20, and over 40, will be excluded.
• • Patients taking preoperative narcotics, patients with extreme sensitivity or allergy to narcotics or local anesthetics, and patients using opioid medications for at least 3 months leading up to surgery, will also be excluded.